FDA Calls for Zantac to Be Taken Off the Market
Zantac is an over-the-counter drug used by many for acid reflux and heartburn. However, new research suggests that it may be causing cancer. According to a recent article, the United States Food and Drug Administration, responsible for regulating drugs across the country, is requesting that manufacturers pull Zantac from the market immediately because an ongoing investigation has found a human carcinogen in it. Apparently, the carcinogen—N-Nitrosodimethylamine or NDMA—can increase in the medication over time, posing a serious risk to public health and Indiana residents who may take the drug.
The FDA has sent letters to manufacturers asking them to withdraw the products from the market. Consumers are advised to stop taking any of the medication they currently have, and to not buy any more. Additionally, consumers are asked to dispose of their unused Zantac, following the instructions in the medication guide or on the FDA website. If consumers need to continue taking medication for acid reflux or heartburn, they can take another approved medication that has not been found to have NDMA in it.
However, Indiana consumers should keep in mind their legal rights if they do get sick after taking the drug. Indiana, like other states, allows those injured by a defective or dangerous product—including an over-the-counter drug—to sue the manufacturers and/or the sellers of the drug in a personal injury lawsuit. Although the effects of Zantac may not be present for a while, individuals who are injured may still be able to file a claim even if they have not taken the drug in months or years.